Expert NetworkExpert InterviewNVS

Slingshot members are talking to an expert! The topic is:

Delving into the recent phase 3 data from the ALIGN clinical trial of Novartis' atrasentan in patients with IgA Nephropathy.

Executed on:Nov 17, 2023 9:00 AM EDT
Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert
Institution: Columbia University
  • Professor of Medicine at Columbia University Medical Center and the Clinical Chief of the Nephrology Division at the New York Presbyterian Hospital.
  • Currently manages 10 patients with ANCA-Associated Vasculitis and  ~40 patients with IgA Nephropathy (IgAN).
  • Clinical and research interests are in glomerular diseases and intensive care nephrology; PI for several multicenter studies and has served on DSMBs.

Interview Goal

This call will discuss the current standard of care and the potential of atrasentan, an oral endothelin A receptor antagonist being developed by Novartis for the treatment of IgA Nephropathy. The focus will be the recent phase 3 data from the ALIGN clinical trial of atrasentan in patients with IgAN.

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.